Read articles from Australia

October 14, 2026 by substack.com

Tobacco harm reduction does not require nicotine to be innocent. It requires honesty about where the greatest harm comes from. Nicotine can cause dependence and should not be promoted casually, but cigarettes are deadly because they burn tobacco and expose users to toxic smoke. The case for safer nicotine products rests on reducing that exposure — not on pretending nicotine has no risks.

October 14, 2026 by planetofthevapes.co.uk

CAPHRA welcomes an Australian opposition proposal to legalise and regulate adult access to vapes and nicotine pouches without prescriptions, but warns against linking it to an 80% cigarette excise cut. The package includes $200 million for enforcement and is projected to raise $8 billion over four years. Australia’s government rejects the proposal, while public health groups warn cheaper cigarettes could increase smoking. CAPHRA argues regulated alternatives—not cheaper cigarettes—would address illicit markets, citing New Zealand’s declining smoking rates since vaping regulation. It urges Canberra to assess legalisation separately from the contentious cigarette tax debate.

October 12, 2026 by substack.com

A snapshot can show where nicotine use is at one moment, but it cannot explain the whole journey. Smoking, vaping and switching are dynamic behaviours, shaped by timing, motivation, access and whether people move fully away from cigarettes. Treating one data point as a final verdict risks missing the direction of change that matters most for harm reduction. Better analysis follows the pathway, not just the photograph.

October 09, 2026 by pearlsandirritations.com

Australia’s nicotine policy is drifting further from the reality consumers are living in. Cigarettes remain legal, illicit tobacco is expanding, and many vapers are navigating workarounds, informal supply or rules that do not match how people actually quit smoking. That gap matters because policy cannot reduce harm effectively while pretending demand has disappeared or that restriction equals control. A better approach would start from real behaviour: keep people inside legal channels, make safer alternatives accessible, and measure success by fewer people smoking.

October 08, 2026 by theconversation.com

Queensland’s enforcement blitz shows that illicit tobacco markets can be disrupted when store closures, serious fines and landlord accountability are used together. The reported rise in legal tobacco sales and doubling of Quitline calls suggest that enforcement can move consumers back into visible channels and prompt interest in quitting. But the measure of success should not be tax-compliant cigarette sales alone. Australia should pair stronger action against illegal supply with expanded cessation support, free nicotine replacement therapy and access to lower-risk alternatives, so the end result is fewer people smoking — not just more people buying cigarettes legally.

October 07, 2026 by substack.com

Public health loses authority when it treats disagreement as a threat rather than a test of its own claims. In nicotine policy, declaring one position beyond challenge can shut out evidence on relative risk, consumer behaviour and the unintended effects of restriction. Confidence is not the same as accountability. Institutions earn trust by showing their reasoning, correcting errors and allowing policy to be questioned when real-world outcomes do not match the promise.

October 06, 2026 by substack.com

A cigarette does not become a public health success because the tax stamp is in order. Legal sales can still mean continued exposure to smoke, disease and premature death, even while governments collect revenue from the product causing the harm. That is the uncomfortable contradiction behind tobacco control built too heavily around compliance. The goal should not be smoke that is properly taxed; it should be fewer people inhaling smoke at all.

October 02, 2026 by protectingtaxpayers.org

The text argues that growing evidence supports tobacco harm reduction products, especially e-cigarettes, as alternatives for adult smokers. It cites a Cochrane review of nine trials finding vaping more effective than traditional nicotine replacement therapies for quitting, with no serious harms identified in those trials. It also describes FDA authorization of reduced-risk marketing claims for ZYN nicotine pouches. The author contends that restrictive policies discourage cessation and fuel illicit markets, while cigarette smoking causes substantial mortality and economic costs. The text urges clinicians and policymakers to prioritize scientific evidence over stigma and prohibition, arguing that access to lower-risk nicotine products could improve public health.

September 25, 2026 by substack.com

Australia’s nicotine debate often talks about systems, markets and enforcement, but the people most affected can disappear from view. Smokers who cannot quit, vapers pushed into prescription workarounds, and consumers navigating illicit supply are not footnotes to policy — they are the evidence of how policy works in practice. A strategy that ignores them may look tidy from above while failing on the ground. Public health should count lived experience as part of the evidence, not as an inconvenience to the model.

September 22, 2026 by substack.com

A smoking rate is only as reliable as the data behind it. Australia’s 5.8% figure raises questions about what is being counted, what may be missed and how illicit tobacco use affects the picture. A low number can shape policy confidence, media narratives and international reputation, so the methods matter. Before Australia is held up as a success story, its smoking data needs to match the reality of the market.